<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The delayed cerebral vasoconstriction known as <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> remains a significant cause of permanent neurological deficit and <z:hpo ids='HP_0011420'>death</z:hpo> following aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> despite the best current medical therapies </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanism of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Several new drugs have been tested in animal models of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>, and these experimental studies have contributed to a better understanding of the potential mechanisms that lead to <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this article, the authors highlight recent advances in the various treatment procedures for delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>(c) 2001 Prous Science </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> rights reserved </plain></SENT>
</text></document>